Litcius/Paper detail

Dopamine D3 receptor-based medication development for the treatment of opioid use disorder: Rationale, progress, and challenges

Ewa Galaj, Amy Hauck Newman, Zheng‐Xiong Xi

2020Neuroscience & Biobehavioral Reviews54 citationsDOIOpen Access PDF

Topics & Concepts

Opioid use disorderBuprenorphineOpioidMedicineMethadone(+)-NaloxoneDopamine receptor D3Substance abusePsychiatryPharmacologyDopamine receptorDopamineInternal medicineReceptorNeurotransmitter Receptor Influence on BehaviorOpioid Use Disorder TreatmentNeuropeptides and Animal Physiology
Dopamine D3 receptor-based medication development for the treatment of opioid use disorder: Rationale, progress, and challenges | Litcius